Literature DB >> 21205766

Metastatic disease in the thoracic and lumbar spine: evaluation and management.

Peter S Rose1, Jacob M Buchowski.   

Abstract

Spinal metastases are found in most patients who die of cancer. The number of patients with symptomatic spinal metastases likely will increase as therapy for the primary disease improves and as cardiovascular mortality decreases. Understanding the epidemiology of metastatic spine disease and its presentation is essential to developing a diagnostic strategy. Treatment may involve chemotherapy, corticosteroids, radiotherapy, surgery, and/or percutaneous procedures (eg, vertebroplasty, kyphoplasty). A rational treatment plan can help improve quality of life, preserve neurologic function, and prolong survival.

Entities:  

Mesh:

Year:  2011        PMID: 21205766     DOI: 10.5435/00124635-201101000-00005

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  33 in total

1.  Prolonged survival following aggressive treatment for metastatic breast cancer in the spine.

Authors:  Patricia L Zadnik; Lee Hwang; Derek G Ju; Mari L Groves; Jackson Sui; Alp Yurter; Timothy F Witham; Ali Bydon; Jean-Paul Wolinsky; Ziya L Gokaslan; Daniel M Sciubba
Journal:  Clin Exp Metastasis       Date:  2013-09-03       Impact factor: 5.150

2.  A validation of the Oswestry Spinal Risk Index.

Authors:  S Whitehouse; J Stephenson; V Sinclair; J Gregory; A Tambe; R Verma; Irfan Siddique; Mohammad Saeed
Journal:  Eur Spine J       Date:  2014-11-13       Impact factor: 3.134

3.  Non-operative management of spinal metastases: A prognostic model for failure.

Authors:  Andrew J Schoenfeld; Joseph H Schwab; Marco L Ferrone; Justin A Blucher; Tracy A Balboni; Lauren B Barton; John H Chi; James D Kang; Elena Losina; Jeffrey N Katz
Journal:  Clin Neurol Neurosurg       Date:  2019-11-04       Impact factor: 1.876

4.  Orthopedic Surgical Treatment and Perioperative Complications in Multiple Myeloma Bone Disease: Analysis of a Series (2009-2018).

Authors:  María Galán-Olleros; Javier Marco; David Oteo; Rafael Cristóbal-Bilbao; Elena Manrique; Roberto García-Maroto; Fernando Marco; Juan Luis Cebrián-Parra
Journal:  Ann Surg Oncol       Date:  2020-07-13       Impact factor: 5.344

5.  Laboratory markers as useful prognostic measures for survival in patients with spinal metastases.

Authors:  Andrew J Schoenfeld; Marco L Ferrone; Peter G Passias; Justin A Blucher; Lauren B Barton; John H Shin; Mitchel B Harris; Joseph H Schwab
Journal:  Spine J       Date:  2019-05-22       Impact factor: 4.166

6.  Prognosticating outcomes and survival for patients with lumbar spinal metastases: Results of a bayesian regression analysis.

Authors:  Andrew J Schoenfeld; Marco L Ferrone; Joseph H Schwab; Justin A Blucher; Lauren B Barton; Mitchel B Harris; James D Kang
Journal:  Clin Neurol Neurosurg       Date:  2019-04-22       Impact factor: 1.876

7.  Palliative considerations in the surgical treatment of spinal metastases: evaluation of posterolateral decompression combined with posterior instrumentation.

Authors:  Jan Walter; Rupert Reichart; Albrecht Waschke; Rolf Kalff; Christian Ewald
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-30       Impact factor: 4.553

Review 8.  Role of rehabilitation medicine and physical agents in the treatment of cancer-associated pain.

Authors:  Andrea L Cheville; Jeffrey R Basford
Journal:  J Clin Oncol       Date:  2014-05-05       Impact factor: 44.544

9.  Metastatic non-Hodgkin lymphoma presenting as low back pain and radiculopathy: a case report.

Authors:  Inger K Roug; Larry B McCartney
Journal:  J Chiropr Med       Date:  2012-09

10.  Outcomes and cost-minimization analysis of cement spacers versus expandable cages for posterior-only reconstruction of metastatic spine corpectomies.

Authors:  Yusef Jordan; Jacob M Buchowski; Mahati Mokkarala; Colleen Peters; David B Bumpass
Journal:  Ann Transl Med       Date:  2019-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.